The latest in a series of meta-analyses of trials assessing viscosupplementation for knee osteoarthritis is the first to raise concerns about its safety. Questions remain, however, regarding the methodological rigour with which the serious adverse events were analyzed, and the biological plausibility of the events reported.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
Drugs & Aging Open Access 01 April 2019
-
Evidence for safety of retreatment with a single intra-articular injection of Gel-200 for treatment of osteoarthritis of the knee from the double-blind pivotal and open-label retreatment clinical trials
BMC Musculoskeletal Disorders Open Access 01 June 2016
-
Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial
Arthritis Research & Therapy Open Access 21 January 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Craig, D. G. et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br. J. Clin. Pharmacol. 73, 285–294 (2012).
Zhang, W. et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16, 137–162 (2008).
Bannuru, R. R. et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 61, 1704–1712 (2009).
Rutjes, A. W. et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann. Intern. Med. http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00473.
Bannuru, R. R., Natov, N. S., Dasi, U. R., Schmid, C. H. & McAlindon, T. E. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthritis Cartilage 19, 1704–1711 (2011).
Bellamy, N. et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD005321. http://dx.doi.org/10.1002/14651858.CD005321.pub2.
Schneeweiss, S. et al. NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib. Pharmacoepidemiol. Drug Saf. 18, 1134–1142 (2009).
Kelly, J. C. Viscosupplementation for knee OA: little gain, big risks. Medscape Medical News [online], (2012).
Huskisson, E. C. & Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford) 38, 602–607 (1999).
Strand, V., Baraf, H. S., Lavin, P. T., Lim, S. & Hosokawa, H. A multicenter, randomized controlled trial comparing a single intra-articular injection of gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 20, 350–356 (2012).
Acknowledgements
T. E. McAlindon is supported by funds from the NIH. R. R. Bannuru is supported by the Agency for Healthcare Research and Quality (grant number F32HS021396). The content of this commentary is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Agency for Healthcare Research and Quality.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
T. E. McAlindon has received speaker's bureau (honoraria) from Bioiberica and has acted as a consultant for Flexion Therapeutics and Sanofi-Aventis, but not with regard to any specific product discussed in this commentary. R. R. Bannuru declares no competing interests.
Rights and permissions
About this article
Cite this article
McAlindon, T., Bannuru, R. Is viscosupplementation really so unsafe for knee OA?. Nat Rev Rheumatol 8, 635–636 (2012). https://doi.org/10.1038/nrrheum.2012.152
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2012.152
This article is cited by
-
Combined intra-articular injection of corticosteroid and hyaluronic acid reduces pain compared to hyaluronic acid alone in the treatment of knee osteoarthritis
Knee Surgery, Sports Traumatology, Arthroscopy (2019)
-
Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
Drugs & Aging (2019)
-
Safety and efficacy of bi-annual intra-articular LBSA0103 injections in patients with knee osteoarthritis
Rheumatology International (2017)
-
Evidence for safety of retreatment with a single intra-articular injection of Gel-200 for treatment of osteoarthritis of the knee from the double-blind pivotal and open-label retreatment clinical trials
BMC Musculoskeletal Disorders (2016)
-
Arthrose
Der Internist (2015)